RECRUITING

Novel Visual Education Tool to Improve Recognition and Reporting of Postpartum Urgent Maternal Warning Signs

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study aims to create a novel visual education tool that builds on the urgent maternal warning signs identified by The Council on Patient Safety in Women's Health Care. Including effective images will improve the understanding of these grave warning signs/symptoms, improving anatomical accuracy while remaining simplistic for patients of varying levels of health care literacy. The investigative team will be focusing on urgent warning signs pertinent to the postpartum period.

Official Title

Novel Visual Education Tool to Improve Recognition and Reporting of Postpartum Urgent Maternal Warning Signs

Quick Facts

Study Start:2025-06-20
Study Completion:2026-08
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06912776

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Postpartum women
  2. * Nulliparity
  3. * Age \>18 years of age
  4. * English speaking patients
  1. * Inability to provide informed written consent
  2. * Refusal to participate in all study-related procedures
  3. * Patients not fluent in English
  4. * Patients with current or history of serious peripartum complications and/or events - such as DVT, PE, peripartum cardiomyopathy, etc. (in which the patient may have received more than standard clinical counseling)
  5. * Patient with comorbidities that potentially require anticoagulation i.e. coagulopathies and may be more prone to DVTs
  6. * Patients with uncorrected visual or hearing impairment
  7. * Healthcare providers (in which patients will have significant background knowledge)

Contacts and Locations

Study Contact

Paul C Fitzgerald, RN,BSN,MS
CONTACT
3126951064
p-fitzgerald2@northwestern.edu

Principal Investigator

Kaitlyn Neumann, MD
PRINCIPAL_INVESTIGATOR
Northwestern University

Study Locations (Sites)

Northwestern Medicine
Chicago, Illinois, 60614
United States

Collaborators and Investigators

Sponsor: Northwestern University

  • Kaitlyn Neumann, MD, PRINCIPAL_INVESTIGATOR, Northwestern University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-06-20
Study Completion Date2026-08

Study Record Updates

Study Start Date2025-06-20
Study Completion Date2026-08

Terms related to this study

Keywords Provided by Researchers

  • Pregnancy
  • Postpartum
  • nulliparus

Additional Relevant MeSH Terms

  • Postpartum